Steffen Pietzke, VP Fin & Chief Acct Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), bought 3,000 shares at $19.00 ($57K) on 2020-07-21, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PDLI | BUY | 2015-12-07 | $75K | — | Filing → |